Quick Answer
Eledon Pharmaceuticals, Inc. reported Research And Development Expense of $66.27 million for the year ending 2025.
- Eledon Pharmaceuticals, Inc. showed an increase of +27.5% in Research And Development Expense from 2024 to 2025.
- This data is from Eledon Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Eledon Pharmaceuticals, Inc.'s Research And Development Expense has grown by 799.1%.
- Historical annual values: Fiscal year 2025: $66.27 million | Fiscal year 2024: $51.96 million | Fiscal year 2023: $30.31 million | Fiscal year 2022: $27.08 million | Fiscal year 2021: $23.74 million | Fiscal year 2020: $6.13 million | Fiscal year 2019: $8.13 million | Fiscal year 2018: $6.82 million | Fiscal year 2017: $2.02 million | Fiscal year 2016: $3.19 million | Fiscal year 2015: $32.64 million | Fiscal year 2014: $14.58 million | Fiscal year 2013: $12.20 million | Fiscal year 2012: $7.37 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: